Tobramycin 80 Mg/2 Ml Fresenius 80 mg/2 ml Solution for injection or infusion
PDF Leaflet Revision Date: 09 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of potentially life-threatening infections.
Dosage (summary)
Adults: 3-5 mg/kg/day; max 5 mg/kg/day for life-threatening infections.
Special Populations
- Elderly
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy; excreted in breast milk.
Key Drug Interactions
- Neuromuscular blocking agents
- Other aminoglycosides
- Potent diuretics
Contraindications
- Allergy to tobramycin
- Pregnancy
- Myasthenia gravis
Common side effects
- Ototoxicity
- Neurotoxicity
- Renal impairment
Counselling Points
- Avoid concurrent use with nephrotoxic drugs
- Monitor for dizziness
- Report any hearing changes
Serious warnings
- Risk of ototoxicity and nephrotoxicity
- Monitor renal function
Important Disclaimer
The Tobramycin 80 Mg/2 Ml Fresenius 80 mg/2 ml Solution for injection or infusion professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
